These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 8911014

  • 21. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.
    Fu TM, Bonneau RH, Epler M, Tevethia MJ, Alam S, Verner K, Tevethia SS.
    Virology; 1996 Aug 01; 222(1):269-74. PubMed ID: 8806508
    [Abstract] [Full Text] [Related]

  • 22. Priming of CD8+ CTL effector cells in mice by immunization with a stress protein-influenza virus nucleoprotein fusion molecule.
    Anthony LS, Wu H, Sweet H, Turnnir C, Boux LJ, Mizzen LA.
    Vaccine; 1999 Jan 28; 17(4):373-83. PubMed ID: 9987177
    [Abstract] [Full Text] [Related]

  • 23. Long-lasting anti-viral cytotoxic T lymphocytes induced in vivo with chimeric-multirestricted lipopeptides.
    Sauzet JP, Déprez B, Martinon F, Guillet JG, Gras-Masse H, Gomard E.
    Vaccine; 1995 Oct 28; 13(14):1339-45. PubMed ID: 8585291
    [Abstract] [Full Text] [Related]

  • 24. Assessment of the specificity of cytotoxic T lymphocytes for the nucleoprotein of Pichinde virus using recombinant vaccinia viruses.
    Ozols DY, Harnish DG, Rawls WE, Rosenthal KL.
    Arch Virol; 1990 Oct 28; 115(3-4):209-25. PubMed ID: 1701987
    [Abstract] [Full Text] [Related]

  • 25. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein.
    Martinon F, Gras-Masse H, Boutillon C, Chirat F, Deprez B, Guillet JG, Gomard E, Tartar A, Levy JP.
    J Immunol; 1992 Nov 15; 149(10):3416-22. PubMed ID: 1385524
    [Abstract] [Full Text] [Related]

  • 26. Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses.
    Ke Y, Li Y, Kapp JA.
    Eur J Immunol; 1995 Feb 15; 25(2):549-53. PubMed ID: 7875219
    [Abstract] [Full Text] [Related]

  • 27. Identification of the immunodominant H-2K(k)-restricted cytotoxic T-cell epitope in the Borna disease virus nucleoprotein.
    Schamel K, Staeheli P, Hausmann J.
    J Virol; 2001 Sep 15; 75(18):8579-88. PubMed ID: 11507203
    [Abstract] [Full Text] [Related]

  • 28. A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells.
    Gallimore A, Hombach J, Dumrese T, Rammensee HG, Zinkernagel RM, Hengartner H.
    Eur J Immunol; 1998 Oct 15; 28(10):3301-11. PubMed ID: 9808199
    [Abstract] [Full Text] [Related]

  • 29. Effects of influenza virus-specific cytotoxic T-lymphocyte responses induced by a synthetic nucleoprotein peptide on the survival of mice challenged with a lethal dose of virus.
    Sastry KJ, Bender BS, Bell W, Small PA, Arlinghaus RB.
    Vaccine; 1994 Nov 15; 12(14):1281-7. PubMed ID: 7856292
    [Abstract] [Full Text] [Related]

  • 30. Mucosal immunization with a measles virus CTL epitope encapsulated in biodegradable PLG microparticles.
    Partidos CD, Vohra P, Jones DH, Farrar GH, Steward MW.
    J Immunol Methods; 1996 Sep 09; 195(1-2):135-8. PubMed ID: 8814328
    [Abstract] [Full Text] [Related]

  • 31. Formaldehyde inactivation of measles virus abolishes CD46-dependent presentation of nucleoprotein to murine class I-restricted CTLs but not to class II-restricted helper T cells.
    Cardoso AI, Beauverger P, Gerlier D, Wild TF, Rabourdin-Combe C.
    Virology; 1995 Sep 10; 212(1):255-8. PubMed ID: 7676641
    [Abstract] [Full Text] [Related]

  • 32. Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells.
    Takahashi H, Nakagawa Y, Yokomuro K, Berzofsky JA.
    Int Immunol; 1993 Aug 10; 5(8):849-57. PubMed ID: 8398980
    [Abstract] [Full Text] [Related]

  • 33. Studies on in vivo induction of HIV-1 envelope-specific cytotoxic T lymphocytes by synthetic peptides from the V3 loop region of HIV-1 IIIB gp 120.
    Nehete PN, Casement KS, Arlinghaus RB, Sastry KJ.
    Cell Immunol; 1995 Feb 10; 160(2):217-23. PubMed ID: 7720083
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.
    Maloy KJ, Donachie AM, O'Hagan DT, Mowat AM.
    Immunology; 1994 Apr 10; 81(4):661-7. PubMed ID: 7518802
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. CD40 ligand preferentially modulates immune response and enhances protection against influenza virus.
    Hashem AM, Gravel C, Chen Z, Yi Y, Tocchi M, Jaentschke B, Fan X, Li C, Rosu-Myles M, Pereboev A, He R, Wang J, Li X.
    J Immunol; 2014 Jul 15; 193(2):722-34. PubMed ID: 24928989
    [Abstract] [Full Text] [Related]

  • 39. Creating CTL targets with epitope-linked beta 2-microglobulin constructs.
    Uger RA, Barber BH.
    J Immunol; 1998 Feb 15; 160(4):1598-605. PubMed ID: 9469415
    [Abstract] [Full Text] [Related]

  • 40. Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction.
    Villacres MC, Behboudi S, Nikkila T, Lovgren-Bengtsson K, Morein B.
    Cell Immunol; 1998 Apr 10; 185(1):30-8. PubMed ID: 9636680
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.